Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model (2022)
- Authors:
- USP affiliated authors: ULRICH, ALEXANDER HENNING - IQ ; BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; FERREIRA, ANA FLAVIA FERNANDES - ICB ; SINGULANI, MONIQUE PATRICIO - FM
- Unidades: IQ; ICB; FM
- DOI: 10.1007/s12035-022-02723-8
- Subjects: FISIOLOGIA; NEUROBIOLOGIA; MODELOS ANIMAIS DE DOENÇAS; DOENÇA DE PARKINSON; MESENCÉFALO; GÂNGLIOS; RECEPTORES DE DOPAMINA; CAMUNDONGOS; IMUNOHISTOQUÍMICA; IMMUNOBLOTTING
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2022
- Source:
- Título do periódico: Molecular Neurobiology
- ISSN: 1559-1182
- Volume/Número/Paginação/Ano: v. 59, p. 1543–1559, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FERREIRA, Ana Flávia Fernandes et al. Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model. Molecular Neurobiology, v. 59, p. 1543–1559, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12035-022-02723-8. Acesso em: 04 jun. 2024. -
APA
Ferreira, A. F. F., Singulani, M. P., Ulrich, H., Feng, Z. -P., Sun, H. -S., & Britto, L. R. G. de. (2022). Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model. Molecular Neurobiology, 59, 1543–1559. doi:10.1007/s12035-022-02723-8 -
NLM
Ferreira AFF, Singulani MP, Ulrich H, Feng Z-P, Sun H-S, Britto LRG de. Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model [Internet]. Molecular Neurobiology. 2022 ; 59 1543–1559.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/s12035-022-02723-8 -
Vancouver
Ferreira AFF, Singulani MP, Ulrich H, Feng Z-P, Sun H-S, Britto LRG de. Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model [Internet]. Molecular Neurobiology. 2022 ; 59 1543–1559.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/s12035-022-02723-8 - Mitochondrial abnormalities in neurological disorders
- Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's disease
- Neuroplasticity induced by the retention period of a complex motor skill learning in rats
- Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model
- The transient receptor potential melastatin 2: a new therapeutical target for Parkinson’s disease?
- Role of acetylcholine receptors in proliferation and differentiation of P19 embryonal carcinoma cells
- Participation of spontaneous 'CA POT. 2+'-transients and 'CA POT. 2+'-fluxes generated by purinergic and nicotinic acetylcholine receptors in neuronal differentiation of P19 embryonic carcinoma cells
- Brilliant blue G, but not fenofibrate, treatment reverts hemiparkinsonian behavior and restores dopamine levels in an animal model of Parkinson's disease
- P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation
- Mechanism of acetylcholine-induced calcium signaling, proliferation and differentiation effects during In vitro neuronal differentiation of embryonal cells
Informações sobre o DOI: 10.1007/s12035-022-02723-8 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
